Exubrion Therapeutics News

Exubrion Therapeutics has a busy winter and spring 2020 ahead. We’ll be showcasing Synovetin OA™ at the following conferences. These are great opportunities to learn firsthand about this breakthrough treatment for canine osteoarthritis (OA)—so be sure to stop by and see us.

 

Texas Veterinary Medical Association (TVMA) 2020 Annual Conference and Expo

When: February 27 – March 1
Where: San Marcos, Texas
Booth: 21

Austin Vet Show 2020

When: April 20-April 21
Where: Austin, Texas
Booth: 215

Synovetin OA™ delivers sustained OA pain relief.1

Synovetin OA™ provides targeted, non-systemic therapy.2

References:

  • Data on file, Exubrion Therapeutics.
  • Fox SM, Donecker JM. Donecker JM, Fox SM. Safety and effectiveness of Synovetin OA™: Results of three randomized trials evaluating treatment of naturally occurring canine elbow osteoarthritis. Exubrion Therapeutics, July 2019.